Beyond The Numbers: 9 Analysts Discuss Abbott Laboratories Stock
Portfolio Pulse from Benzinga Insights
Abbott Laboratories (NYSE:ABT) has been analyzed by 9 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $128.22, with recent upgrades from several analysts. Abbott's financial health is strong, with high net margins and effective debt management.
October 14, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott Laboratories has received mixed analyst ratings, with a current average price target of $128.22. Recent upgrades from analysts suggest a positive outlook, supported by strong financial metrics like high net margins and effective debt management.
The article highlights recent analyst upgrades and a higher average price target for Abbott Laboratories, indicating a positive short-term outlook. The company's strong financial health, including high net margins and effective debt management, further supports this sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100